Important Notice
The Company specifically reminds investors to carefully read the full content of this prospectus and pay special attention to the following important matters before making investment decisions or value judgments.
I. Overview of the Issuance of A-Shares to Specific Targets
-
Matters related to this issuance of shares to specific targets have been approved by the 24th meeting of the 4th Board of Directors, the 2026 First Extraordinary General Meeting of Shareholders, and the 27th meeting of the 4th Board of Directors, and have been approved by the state-owned assets supervision and administration department or its authorized unit. The issuance plan is subject to review and approval by the Shenzhen Stock Exchange and the registration approval by the China Securities Regulatory Commission (CSRC) before implementation.
-
The targets of this issuance include no more than 35 (inclusive) specific investors that meet the conditions stipulated by the CSRC, including China Gold Group, securities investment fund management companies, securities companies, trust investment companies, finance companies, insurance institutional investors, qualified foreign institutional investors, and other legal persons, natural persons, or other qualified investors stipulated by the CSRC. China Gold Group is the controlling shareholder of the Company and will subscribe for 100 million RMB of the shares issued. Other shares will be subscribed by other specific targets.
-
The pricing benchmark date for this issuance is the first day of the issuance period. The issuance price shall be the higher of 80% of the average trading price of the Company's shares for the 20 trading days preceding the pricing benchmark date or the audited net asset value per share attributable to ordinary shareholders of the parent company as of the most recent period prior to the issuance.
-
The number of shares to be issued shall be calculated by dividing the total proceeds by the final issuance price determined through competitive bidding, and shall not exceed 30% of the total share capital before the issuance, i.e., not exceeding 79,200,569 shares (inclusive).
-
The total proceeds from this issuance shall not exceed 800 million RMB (inclusive). After deducting relevant issuance expenses, the net proceeds are intended to be used for the following projects:
| No. | Project Name | Total Investment (10k RMB) | Proposed Proceeds (10k RMB) |
|---|---|---|---|
| 1 | Zhongjin Irradiation Changsha Sterilization Technology Service Center Project | 40,000.00 | 10,000.00 |
| 2 | Hefei Comprehensive Sterilization Technology Center Project | 40,000.00 | 20,000.00 |
| 3 | Zhongjin Health Technology (Jiaxing) Co., Ltd. Annual Sterilization of 300,000 Cubic Meters of Medical Devices Project (Phase II) | 10,844.00 | 10,000.00 |
| 4 | Cobalt Source Procurement Project | 34,000.00 | 34,000.00 |
| 5 | Supplementing Working Capital | 6,000.00 | 6,000.00 |
| Total | 130,844.00 | 80,000.00 |
-
Shares subscribed by China Gold Group shall not be transferred within 18 months from the date of completion of the issuance, and shares subscribed by other targets shall not be transferred within 6 months.
-
The accumulated undistributed profits of the Company prior to this issuance shall be shared by both new and existing shareholders upon completion of the issuance.
-
To further standardize and improve the Company's profit distribution policy, the Company has formulated the "Future Three-Year (2025-2027) Shareholder Dividend Return Plan."
-
In accordance with relevant requirements regarding the dilution of immediate returns, the Company has analyzed the impact of this issuance on immediate returns and proposed specific measures to fill the gap. Investors should note that these measures do not constitute a guarantee of future profits.
-
This issuance does not constitute a major asset restructuring and will not lead to changes in the Company's controlling shareholder or actual controller.